4.5 Review

Visual snow syndrome: what we know so far

期刊

CURRENT OPINION IN NEUROLOGY
卷 31, 期 1, 页码 52-58

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WCO.0000000000000523

关键词

palinopsia; persistent visual phenomena; photophobia; visual snow; visual static

资金

  1. Eye on Vision Foundation, Sierra Domb
  2. German Research Foundation
  3. German Migraine and Headache Society
  4. Research to Prevent Blindness, Inc., New York, NY
  5. Allergan
  6. Amgen
  7. Eli-Lilly and Company
  8. Akita Biomedical
  9. Alder Biopharmaceuticals
  10. Avanir Pharma
  11. Cipla Ltd
  12. Dr Reddy's Laboratories
  13. eNeura
  14. Electrocore LLC
  15. Novartis
  16. Pfizer Inc
  17. Quest Diagnostics
  18. Scion
  19. Teva Pharmaceuticals
  20. Trigemina Inc.
  21. MedicoLegal work
  22. Journal Watch
  23. Up-to-Date
  24. Massachusetts Medical Society
  25. Oxford University Press

向作者/读者索取更多资源

Purpose of reviewWe provide an overview of the neurological condition known as visual snow syndrome. Patients affected by this chronic disorder suffer with a pan-field visual disturbance described as tiny flickering dots, which resemble the static noise of an untuned television.Recent findingsThe term visual snow' has only appeared in the medical literature very recently. The clinical features of the syndrome have now been reasonably described and the pathophysiology has begun to be explored. This review focuses on what is currently known about visual snow.SummaryRecent evidence suggests visual snow is a complex neurological syndrome characterized by debilitating visual symptoms. It is becoming better understood as it is systematically studied. Perhaps the most important unmet need for the condition is a sufficient understanding of it to generate and test hypotheses about treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据